How should I evaluate and manage leg pain after bilateral radiofrequency ablation (RFA) of the great saphenous veins (GSV) and small saphenous veins (SSV) and placement of an iliac vein stent?

Evaluation and Management of Leg Pain After Bilateral RFA and Iliac Vein Stenting

Immediately obtain duplex ultrasound imaging to rule out stent-related complications including thrombosis, stenosis, or migration, as routine early surveillance after iliac vein stent placement is essential for detecting potentially serious adverse events 1.

Initial Diagnostic Approach

Your first priority is to exclude stent complications, which can be life-threatening. The 2024 consensus guidelines explicitly recommend routine early clinical surveillance with imaging after iliac vein stent placement 1. Specifically assess for:

• Stent thrombosis or stenosis - can present as new or worsening leg pain and swelling
• Stent migration - particularly concerning with stents <60mm in length 1
• Deep vein thrombosis - though rare, must be excluded

Use either duplex ultrasound or axial imaging (CT/MR venography) per your preference 1. Ultrasound is typically more accessible and avoids radiation.

Common Post-RFA Pain Patterns

If stent complications are excluded, consider typical post-RFA sequelae:

Expected Post-Procedure Pain

• RFA typically causes mild postoperative pain (VAS scores 1.85±0.35 on day 1, decreasing to 0.59±0.21 by day 3) 2
• Pain usually resolves within the first 2 weeks 3
• The "string" or "tourniquet" sensation along the ablated vein tract occurs in approximately 50% of patients initially but typically resolves 4

Persistent Pain Beyond 2 Weeks

If pain persists beyond the expected recovery period, evaluate for:

1. Incomplete venous treatment - residual superficial or deep venous reflux not addressed by the procedures
2. Phlebitis along ablated vein segments - presents as tender, palpable cord
3. Inadequate iliac vein stent expansion - may cause persistent venous hypertension

Management Algorithm

For Early Post-Procedure Pain (Days 1-14):

• Topical therapy: Apply combination gel containing escin, heparin, and essential phospholipids twice daily for 2 weeks - this reduces "string" symptoms in 93.5% of cases 4
• Simple analgesics as needed (most patients require minimal pain medication) 2
• Compression therapy continuation

For Persistent Pain (>2 weeks):

Step 1: Imaging Confirmation

• Repeat duplex ultrasound of both legs including stent assessment
• If ultrasound inadequate, proceed to CT or MR venography 1

Step 2: Address Identified Pathology

• Stent stenosis/thrombosis: Requires anticoagulation and possible reintervention
• Residual superficial reflux: May need additional ablation or sclerotherapy
• Phlebitis: Topical anti-inflammatory therapy, NSAIDs

Step 3: Assess for Treatment Failure Factors If imaging shows patent stent and occluded treated veins but symptoms persist, consider:

• Diuretic use - particularly furosemide 20mg or dual diuretics (furosemide + hydrochlorothiazide) are associated with persistent swelling despite successful endovascular treatment 5
• Other causes of edema - cardiac, renal, lymphatic, medications (calcium channel blockers)

Critical Pitfalls to Avoid

1. Do not assume pain is "normal" without imaging - stent migration and thrombosis require urgent intervention 1

2. Do not overlook bilateral symptoms - while you treated both legs, bilateral persistent swelling suggests systemic causes rather than venous insufficiency alone 1

3. Do not continue diuretics expecting improvement - diuretic use paradoxically correlates with treatment failure in venous disease 5

4. Do not delay follow-up imaging - the guidelines emphasize both early AND long-term surveillance is necessary given limited long-term data on venous stents 1

Anticoagulation Considerations

You likely do not need anticoagulation or antiplatelet therapy unless the patient has additional thrombotic risk factors (inherited thrombophilia, active cancer, chronic inflammatory conditions) 1. The 2024 consensus states there is no consensus that anticoagulation is necessary in NIVL patients without prior VTE history 1. However, if thrombotic complications are identified on imaging, anticoagulation becomes mandatory.

Long-Term Surveillance

Continue clinical and imaging surveillance beyond the immediate post-operative period. Iliac vein stents have 96-99% long-term patency, but the lack of extensive long-term data on dedicated venous stents justifies ongoing monitoring 1. Schedule follow-up imaging at 6 months and annually thereafter.